Drug Shortage Report for OLUX-E
Report ID | 57602 |
Drug Identification Number | 02344408 |
Brand name | OLUX-E |
Common or Proper name | Clobestal Proprionate |
Company Name | MAYNE PHARMA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLOBETASOL PROPIONATE |
Strength(s) | 0.05% |
Dosage form(s) | AEROSOL, FOAM |
Route of administration | TOPICAL |
Packaging size | 10 g and 100 g |
ATC code | D07AD |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-09-30 |
Actual start date | 2018-08-03 |
Estimated end date | 2019-02-28 |
Actual end date | 2018-09-28 |
Shortage status | Resolved |
Updated date | 2021-08-13 |
Company comments | Unable to identify a Canadian distributor |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1240 SUGG PARKWAY GREENVILLE, NORTH CAROLINA UNITED STATES 27834 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-08-13 | French | Compare |
v4 | 2021-08-13 | English | Compare |
v3 | 2018-08-07 | French | Compare |
v2 | 2018-08-07 | French | Compare |
v1 | 2018-08-07 | English | Compare |
Showing 1 to 5 of 5